• Study on Tralokinumab for Children Aged 6-11 with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France The Netherlands Spain

  • Study on the Effectiveness and Safety of Cisplatin, Carboplatin, Etoposide, and Durvalumab in Patients with Limited Stage Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Long-term safety study of filgotinib tablets in adults with ulcerative colitis who completed previous filgotinib treatment

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Hungary

  • Study of BMS-986446 for Early Alzheimer’s Disease Patients

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Belgium Spain Sweden

  • Study of Irinotecan with FOLFOX and Bevacizumab for Patients with Unresectable Colorectal Cancer Metastases

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study of Durvalumab and Tremelimumab with Y-90 SIRT for Patients with Intermediate Stage Liver Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study Comparing Isatuximab with Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Germany Greece Italy The Netherlands +2

  • Study of Paclitaxel, Carboplatin and Letrozole Treatment Compared to Letrozole Alone in Patients with Stage II-IV Low-Grade Serous Ovarian or Peritoneal Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Ireland

  • Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    4 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +9

  • Study on the Effects of Selgantolimod and NUC Discontinuation in Patients with Chronic Hepatitis B

    Not recruiting

    2 1 1 1
    Investigated drugs:
    France Germany Italy Spain

powered by